Chimerix Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chimerix Inc with three other
companies in this sector in UNITED STATES :
ProPhase Labs Inc
sales of $9.88 million
China Pharma Holdings, Inc.
of which 100%
was research and development of epicutaneous).
Chimerix Inc reported sales of $12.52 million
December of 2019.
increase of 73.5%
versus 2018, when the company's sales were $7.22 million.